News

Stories

See all

How to Prevent the Next Pandemic: Antimicrobial Resistance

View Story

Juan Granados-Zúñiga

Juan Granados-Zúñiga, Lilly Pride Chair, Says ‘Be Yourself’

View Story

Updates: Lilly's Global COVID-19 Response

View Story

Progress in Migraine Care: Much to Celebrate, Much to Do

View Story

Indy Day of Solidarity – We Stand Together on June 13

View Story

Lilly Accelerates Cancer R&D with Speed and Precision

View Story


Press Releases

See all

Central Indiana Racial Equity Fund Launches with more than $2.2 Million in Initial Commitments

June 25, 2020

Tags |  Corporate

The fund, established by the Eli Lilly and Company Foundation, Lumina Foundation and Central Indiana Community Foundation, will focus on solutions that address racial inequities in the criminal justice system INDIANAPOLIS , June 25, 2020 /PRNewswire/ -- A coalition of local stakeholders has




Lilly launches program about what people with diabetes should "Know Before the Low™"

June 24, 2020

Tags |  Product

Singer/songwriter Crystal Bowersox kicks off the educational initiative by encouraging people to educate their support network and develop a plan for low blood sugar and very low blood sugar emergencies INDIANAPOLIS , June 24, 2020 /PRNewswire/ -- About 34 million Americans live with diabetes, and




Full results from EMPERIAL exercise ability trials presented

June 19, 2020

Tags |  Product

RIDGEFIELD, Conn. and INDIANAPOLIS, June 19, 2020 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced full results from the EMPERIAL-Reduced and EMPERIAL-Preserved trials related to exercise ability and symptom improvement with Jardiance ® (empagliflozin) in




Emgality® Demonstrates Reduction in Frequency, Duration, and Pain Severity in Patients with Episodic and Chronic Migraine

June 17, 2020

Tags |  Product

INDIANAPOLIS , June 17, 2020 /PRNewswire/ -- Emgality ® (galcanezumab-gnlm) reduces total pain burden in a recent analysis of patients with episodic and chronic migraine. Total pain burden is a patient-centric measure that combines the monthly frequency, duration, and pain severity of migraine.